NovaBridge Biosciences (NBP) Net Cash Flow (2019 - 2025)
NovaBridge Biosciences (NBP) posted quarterly Net Cash Flow of -$17.6 million for Q4 2025, down 59.33% year-on-year from -$43.3 million in Q4 2024, and down 128.15% on a QoQ basis from $62.6 million in Q3 2025.
NovaBridge Biosciences (NBP) Net Cash Flow (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Net Cash Flow for 4 consecutive years, with -$17.6 million the latest figure, recorded in Q4 2025.
- Quarterly Net Cash Flow fell 59.33% year-over-year to -$17.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $45.0 million (up 153.35% YoY) and the FY2025 annual result came in at $142.1 million, up 175.17% from the prior year.
- Net Cash Flow eased to -$17.6 million in Q4 2025 per NBP's latest filing, from $62.6 million in the prior quarter.
- Over the last five years, Net Cash Flow for NBP reached as high as $62.6 million in Q3 2025 and fell as low as -$73.2 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | NovaBridge Biosciences | 389.86 Mn | 389.86 Mn | - | -17.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -17.62 Mn |
| Dec 31, 2025 | -17.62 Mn |
| Sep 30, 2025 | 62.59 Mn |
| Sep 30, 2025 | 62.59 Mn |
| Dec 31, 2024 | -11.06 Mn |
| Dec 31, 2024 | -11.06 Mn |
| Sep 30, 2024 | -73.23 Mn |
| Sep 30, 2024 | -73.23 Mn |
| Dec 31, 2020 | 289.03 Mn |
| Dec 31, 2020 | 289.03 Mn |
| Sep 30, 2020 | 239.14 Mn |
| Sep 30, 2020 | 239.14 Mn |
| Dec 31, 2019 | -3.60 Mn |
| Dec 31, 2019 | -3.60 Mn |